Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Effect of Surgical Technique on Corneal Implant Performance.

Ljunggren MK, Elizondo RA, Edin E, Olsen D, Merrett K, Lee CJ, Salerud G, Polarek J, Fagerholm P, Griffith M.

Transl Vis Sci Technol. 2014 Apr 15;3(2):6. eCollection 2014 Apr. Erratum in: Transl Vis Sci Technol. 2018 Nov 14;7(6):8.

2.

Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold.

Fagerholm P, Lagali NS, Ong JA, Merrett K, Jackson WB, Polarek JW, Suuronen EJ, Liu Y, Brunette I, Griffith M.

Biomaterials. 2014 Mar;35(8):2420-7. doi: 10.1016/j.biomaterials.2013.11.079. Epub 2013 Dec 25.

3.

Fabrication of a human recombinant collagen-based corneal substitute using carbodiimide chemistry.

Islam MM, Griffith M, Merrett K.

Methods Mol Biol. 2013;1014:157-64. doi: 10.1007/978-1-62703-432-6_10.

PMID:
23690011
4.

Crosslinked collagen hydrogels as corneal implants: effects of sterically bulky vs. non-bulky carbodiimides as crosslinkers.

Ahn JI, Kuffova L, Merrett K, Mitra D, Forrester JV, Li F, Griffith M.

Acta Biomater. 2013 Aug;9(8):7796-805. doi: 10.1016/j.actbio.2013.04.014. Epub 2013 Apr 22.

PMID:
23619290
5.

Epoxy cross-linked collagen and collagen-laminin Peptide hydrogels as corneal substitutes.

Koh LB, Islam MM, Mitra D, Noel CW, Merrett K, Odorcic S, Fagerholm P, Jackson WB, Liedberg B, Phopase J, Griffith M.

J Funct Biomater. 2013 Aug 28;4(3):162-77. doi: 10.3390/jfb4030162.

6.

Biosynthetic corneal implants for replacement of pathologic corneal tissue: performance in a controlled rabbit alkali burn model.

Hackett JM, Lagali N, Merrett K, Edelhauser H, Sun Y, Gan L, Griffith M, Fagerholm P.

Invest Ophthalmol Vis Sci. 2011 Feb 3;52(2):651-7. doi: 10.1167/iovs.10-5224.

PMID:
20847116
7.

A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study.

Fagerholm P, Lagali NS, Merrett K, Jackson WB, Munger R, Liu Y, Polarek JW, Söderqvist M, Griffith M.

Sci Transl Med. 2010 Aug 25;2(46):46ra61. doi: 10.1126/scitranslmed.3001022.

8.

Corneal regeneration following implantation of a biomimetic tissue-engineered substitute.

Fagerholm P, Lagali NS, Carlsson DJ, Merrett K, Griffith M.

Clin Transl Sci. 2009 Apr;2(2):162-4. doi: 10.1111/j.1752-8062.2008.00083.x. No abstract available. Erratum in: Clin Transl Sci. 2014 Aug;7(4):347.

9.

Synthetic neoglycopolymer-recombinant human collagen hybrids as biomimetic crosslinking agents in corneal tissue engineering.

Merrett K, Liu W, Mitra D, Camm KD, McLaughlin CR, Liu Y, Watsky MA, Li F, Griffith M, Fogg DE.

Biomaterials. 2009 Oct;30(29):5403-8. doi: 10.1016/j.biomaterials.2009.06.016. Epub 2009 Jul 2.

PMID:
19576630
10.

Artificial corneas: a regenerative medicine approach.

Griffith M, Jackson WB, Lagali N, Merrett K, Li F, Fagerholm P.

Eye (Lond). 2009 Oct;23(10):1985-9. doi: 10.1038/eye.2008.409. Epub 2009 Jan 16. Review.

PMID:
19151645
11.

Tissue-engineered recombinant human collagen-based corneal substitutes for implantation: performance of type I versus type III collagen.

Merrett K, Fagerholm P, McLaughlin CR, Dravida S, Lagali N, Shinozaki N, Watsky MA, Munger R, Kato Y, Li F, Marmo CJ, Griffith M.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3887-94. doi: 10.1167/iovs.07-1348. Epub 2008 May 30.

PMID:
18515574
12.

A biomimetic scaffold for culturing limbal stem cells: a promising alternative for clinical transplantation.

Dravida S, Gaddipati S, Griffith M, Merrett K, Lakshmi Madhira S, Sangwan VS, Vemuganti GK.

J Tissue Eng Regen Med. 2008 Jul;2(5):263-71. doi: 10.1002/term.91.

PMID:
18512269
13.

Innervation of tissue-engineered recombinant human collagen-based corneal substitutes: a comparative in vivo confocal microscopy study.

Lagali N, Griffith M, Fagerholm P, Merrett K, Huynh M, Munger R.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3895-902. doi: 10.1167/iovs.07-1354. Epub 2008 Apr 11.

PMID:
18408185
14.

Recombinant human collagen for tissue engineered corneal substitutes.

Liu W, Merrett K, Griffith M, Fagerholm P, Dravida S, Heyne B, Scaiano JC, Watsky MA, Shinozaki N, Lagali N, Munger R, Li F.

Biomaterials. 2008 Mar;29(9):1147-58.

PMID:
18076983
15.

Properties of porcine and recombinant human collagen matrices for optically clear tissue engineering applications.

Liu Y, Griffith M, Watsky MA, Forrester JV, Kuffova L, Grant D, Merrett K, Carlsson DJ.

Biomacromolecules. 2006 Jun;7(6):1819-28.

PMID:
16768403
16.

Interactions of corneal cells with transforming growth factor beta 2-modified poly dimethyl siloxane surfaces.

Merrett K, Griffith CM, Deslandes Y, Pleizier G, Dubé MA, Sheardown H.

J Biomed Mater Res A. 2003 Dec 1;67(3):981-93.

PMID:
14613248
17.

Surface analysis methods for characterizing polymeric biomaterials.

Merrett K, Cornelius RM, McClung WG, Unsworth LD, Sheardown H.

J Biomater Sci Polym Ed. 2002;13(6):593-621. Review.

PMID:
12182547
18.

Adhesion of corneal epithelial cells to cell adhesion peptide modified pHEMA surfaces.

Merrett K, Griffith CM, Deslandes Y, Pleizier G, Sheardown H.

J Biomater Sci Polym Ed. 2001;12(6):647-71.

PMID:
11556742
19.

Circulatory arrest induced by intermittent positive pressure ventilation in a patient with severe asthma.

Rosengarten PL, Tuxen DV, Dziukas L, Scheinkestel C, Merrett K, Bowes G.

Anaesth Intensive Care. 1991 Feb;19(1):118-21. No abstract available.

PMID:
2012271
20.

The Chalk River Nuclear Laboratories respirator program.

White JM, Merrett KW.

Am Ind Hyg Assoc J. 1968 Nov-Dec;29(6):601-4. No abstract available.

PMID:
5249176

Supplemental Content

Loading ...
Support Center